Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
235 hedge funds and large institutions have $3.89B invested in Arena Pharmaceuticals Inc in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 82 increasing their positions, 90 reducing their positions, and 38 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
67% more call options, than puts
Call options by funds: $28.4M | Put options by funds: $17M
9% less repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 90
7% less capital invested
Capital invested by funds: $4.17B → $3.89B (-$279M)
7% less funds holding
Funds holding: 254 → 235 (-19)
42% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 38
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$142M |
| 2 |
EMG
ETF Managers Group
Summit,
New Jersey
|
+$37.4M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$25.2M |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$21.4M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
+$18.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$39M |
| 2 |
State Street
Boston,
Massachusetts
|
-$24.8M |
| 3 |
UBS AM
Chicago,
Illinois
|
-$18.6M |
| 4 |
Goldman Sachs
New York
|
-$17.9M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$14.6M |
ARNA Hedge Fund Activity: Q1 2021 in Review
235 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q1 2021, worth a combined $3.89B — down 6.7% from $4.17B a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of ARNA and 22 opened new positions — a net loss of 16 holders — while 90 trimmed existing stakes and 82 added.
The largest buyer was Wellington Management Group, adding an estimated $142M. The largest seller was Victory Capital Management, cutting an estimated $39M.
- 235 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q1 2021, down from 254 in Q4 2020.
- Funds reported $3.89B of Arena Pharmaceuticals Inc stock for Q1 2021, down 6.7% quarter-over-quarter.
- 22 funds opened new Arena Pharmaceuticals Inc positions in Q1 2021 and 38 closed out, a net change of -16 holders.
- The largest Arena Pharmaceuticals Inc buyer in Q1 2021 was Wellington Management Group, an estimated $142M added.
- The largest Arena Pharmaceuticals Inc seller in Q1 2021 was Victory Capital Management, an estimated $39M sold.
Based on aggregated 13F filings for Q1 2021.